This work has been supported by grants from the Fondazione Cariplo, Milan, Italy (grant no.: 2011-0470), The Wellcome Trust (Programme 086867/Z/08/Z) and, in part, The William Harvey Research Foundation (London, UK). I.L. Ph.D. training at the Scuola di Alta Formazione of the University of East Piendmont was supported by the Compagnia di San Paolo (Turin, Italy) and partially by the Fondazione Cariplo (NutriAl Network 2010)
BACKGROUND/AIMS: The molecular mechanisms leading to Non-Alcoholic Steatohepatitis (NASH) are not fu...
Annexin A1 (ANXA1) is an endogenously produced anti-inflammatory protein, which plays an important r...
Annexin A1 (ANXA1) is an endogenously produced anti-inflammatory protein, which plays an important r...
Macrophage-derived AnxA1 plays a functional role in modulating hepatic inflammation and fibrogenesis...
Annexin A1 (AnxA1) is an effector of the resolution of inflammation and is highly effective in termi...
: Annexin A1 (AnxA1) is an important effector in the resolution of inflammation which is involved in...
Annexin A1 (AnxA1) is an effector of the resolution of inflammation and is highly effective in termi...
Objective and design: We have previously reported a role for annexin-A1 in liver proliferation and t...
Non-alcoholic fatty liver disease (NAFLD) is becoming the most common form of liver injury worldwid...
Annexin A1 (ANXA1) has long been classed as an anti-inflammatory protein due to its control over leu...
This work was supported by a collaborative project between Unigene Corp. and Queen Mary University...
This work was supported by a Wellcome Trust (UK) project grant 083551. SMO is funded by Fundação de ...
Glucocorticoids are used therapeutically for their anti-inflammatory and immunosuppressive actions. ...
PMCID: PMC3212807This is an Open Access article distributed under the terms of the Creative Commons ...
Inflammation is the body's innate immune response to the damage caused to its cells and vascularised...
BACKGROUND/AIMS: The molecular mechanisms leading to Non-Alcoholic Steatohepatitis (NASH) are not fu...
Annexin A1 (ANXA1) is an endogenously produced anti-inflammatory protein, which plays an important r...
Annexin A1 (ANXA1) is an endogenously produced anti-inflammatory protein, which plays an important r...
Macrophage-derived AnxA1 plays a functional role in modulating hepatic inflammation and fibrogenesis...
Annexin A1 (AnxA1) is an effector of the resolution of inflammation and is highly effective in termi...
: Annexin A1 (AnxA1) is an important effector in the resolution of inflammation which is involved in...
Annexin A1 (AnxA1) is an effector of the resolution of inflammation and is highly effective in termi...
Objective and design: We have previously reported a role for annexin-A1 in liver proliferation and t...
Non-alcoholic fatty liver disease (NAFLD) is becoming the most common form of liver injury worldwid...
Annexin A1 (ANXA1) has long been classed as an anti-inflammatory protein due to its control over leu...
This work was supported by a collaborative project between Unigene Corp. and Queen Mary University...
This work was supported by a Wellcome Trust (UK) project grant 083551. SMO is funded by Fundação de ...
Glucocorticoids are used therapeutically for their anti-inflammatory and immunosuppressive actions. ...
PMCID: PMC3212807This is an Open Access article distributed under the terms of the Creative Commons ...
Inflammation is the body's innate immune response to the damage caused to its cells and vascularised...
BACKGROUND/AIMS: The molecular mechanisms leading to Non-Alcoholic Steatohepatitis (NASH) are not fu...
Annexin A1 (ANXA1) is an endogenously produced anti-inflammatory protein, which plays an important r...
Annexin A1 (ANXA1) is an endogenously produced anti-inflammatory protein, which plays an important r...